¿Cuál es el protocolo de actuación ante un shock?

Respuesta generada por Itaca · 45 fuentes · 13 de marzo de 2026

Pregunta original

Protocolo de actuación Shok 2026 en idioma español

I cannot determine what “Shok 2026” refers to (e.g., a specific hospital/network document, a regional EMS algorithm, or a branded protocol). If you share the issuing organization/country and a link or PDF title, I can help summarize and critically appraise it. Also, I can only provide responses in English.

Executive summary (evidence-based “adult shock” action protocol, usable as a 2026 template)

Across etiologies, early shock care should prioritize (1) rapid recognition and phenotyping, (2) immediate stabilization of airway/oxygenation and perfusion, and (3) cause-directed therapy in parallel with resuscitation, because delay in definitive therapy (e.g., antibiotics/source control in septic shock; reperfusion in AMI-related shock) worsens outcomes SSC 2021 [1] ESC ACS 2023 [2]. For septic shock, current high-level guidance supports early antimicrobials, early fluids, and norepinephrine-first vasopressor strategy with a pragmatic MAP target around 65 mmHg in most adults SSC 2021 [1]. For AMI-related cardiogenic shock, management is anchored in urgent coronary revascularization strategy and selective escalation to mechanical circulatory support; routine IABP has not shown mortality benefit ESC ACS 2023 [2] NEJM 2012 IABP-SHOCK II [3].

1) First 5–10 minutes: universal stabilization

  • rapid phenotyping
    Primary goals: prevent immediate death from hypoxemia/airway failure, and restore perfusion while identifying the dominant shock phenotype (distributive vs cardiogenic vs hypovolemic vs obstructive; mixed forms are common) SSC 2021 [1].

Actions (performed in parallel):

  • A/B: airway assessment; oxygen; ventilatory support if needed to reduce work of breathing and improve oxygen delivery (context-dependent) SSC 2021 [1].
  • C: continuous ECG, BP (consider arterial line early in unstable patients), pulse oximetry; obtain large-bore IV access; draw labs including lactate, CBC, CMP, coagulation, ABG/VBG as available SSC 2021 [1].
  • Focused bedside evaluation (history, exam, ECG, point-of-care ultrasound if available) to rapidly separate likely septic shock vs AMI-related cardiogenic shock and trigger the appropriate pathway early SSC 2021 [1] ESC ACS 2023 [2].

Clinical decision point: if hypotension is severe and persistent, initiate vasopressors promptly (even via a well-functioning peripheral line as a bridge, per local policy) rather than waiting for prolonged fluid administration—particularly when cardiogenic shock is plausible or fluid intolerance is likely SSC 2021 [1].

2) Septic shock pathway (when distributive shock is most likely)

Trigger: suspected/confirmed infection + vasopressor requirement to maintain perfusion and/or signs of hypoperfusion; treat as time-critical SSC 2021 [1].

Core bundle elements (adult):

  • Antibiotics: administer promptly after cultures if this does not meaningfully delay therapy; urgency is highest in septic shock SSC 2021 [1].
  • Fluids: crystalloid resuscitation early; the common initial approach is ~30 mL/kg in the first hours in patients with hypoperfusion, but SSC emphasizes individualized reassessment and acknowledges uncertainty/heterogeneity in fluid responsiveness and harms (especially in HF/CKD) SSC 2021 [1].
  • Vasopressors: norepinephrine first-line to target a MAP ~65 mmHg for most adults, then titrate to organ perfusion; add a second agent (e.g., vasopressin) when escalating norepinephrine or to reduce catecholamine exposure (strategy individualized) SSC 2021 [1].
  • Reassessment: repeated evaluation of perfusion (mental status, capillary refill, urine output) and lactate trends to guide ongoing resuscitation and avoid iatrogenic fluid overload SSC 2021 [1].
  • Source control: identify and control the source as soon as feasible (drainage, surgery, device removal), coordinated with hemodynamic stabilization SSC 2021 [1].

Key uncertainty (clinically important): outside of “early rescue” resuscitation, the optimal fluid strategy (volume, rate, dynamic measures) is not one-size-fits-all; SSC recommendations include multiple “suggestions” rather than uniformly strong directives, reflecting limited certainty in several domains SSC 2021 [1].

3) AMI-related cardiogenic shock pathway (when cardiogenic shock is most likely)

Trigger: shock with evidence of ACS/AMI or acute pump failure; treat as a systems-of-care emergency with early cardiology/ICU involvement (“shock team” model where available) ESC ACS 2023 [2].

Core actions:

  • Immediate reperfusion strategy: urgent invasive evaluation and revascularization planning per ACS guidance; in AMI with multivessel disease and shock, an initial strategy focusing on the culprit lesion (with possible staged non-culprit PCI) is supported in contemporary ESC guidance ESC ACS 2023 [2].
  • Mechanical support (principles):
  • Do not use IABP routinely in AMI-related cardiogenic shock, as randomized evidence did not show mortality benefit when added to early revascularization strategies NEJM 2012 IABP-SHOCK II [3].
  • Escalation to other temporary mechanical circulatory support should be individualized (phenotype, severity, complications, local expertise). Comparative superiority across devices should not be assumed without head-to-head randomized evidence in the same phenotype.
  • Hemodynamic strategy: vasopressors/inotropes are typically used to maintain perfusion while definitive therapy proceeds; selection and titration are guided by BP, congestion, lactate, echo findings, and (in many centers) invasive hemodynamics ESC ACS 2023 [2].

Key uncertainty (clinically important): cardiogenic shock is highly heterogeneous (LV failure, RV failure, mechanical complications, mixed distributive components post-arrest), so protocolized “one device/one drug” approaches are risky; local pathways should explicitly define eligibility criteria for escalation and mandatory reassessment checkpoints ESC ACS 2023 [2].

4) Practical reassessment checkpoints (applies to all shock phenotypes)

At minimum, reassess every 10–15 minutes during active resuscitation and after each intervention (fluid bolus, vasopressor titration, ventilation change), using a consistent set of endpoints to avoid “treating the number” alone SSC 2021 [1]:

  • Perfusion: mental status, skin temperature/mottling, capillary refill, urine output.
  • Hemodynamics: MAP and pulse pressure trends; consider dynamic tests of fluid responsiveness where feasible.
  • Metabolic: lactate trend (interpret in clinical context; non-hypoperfusion causes exist).

What I need from you to provide the exact “Shok 2026” protocol in Spanish

Please paste the cover page text or share: (1) the issuing institution/region, (2) whether this is prehospital EMS vs ED/ICU, and (3) the shock type focus (septic vs cardiogenic vs trauma). Then I can (a) extract the steps, (b) check them against guideline-level evidence, and (c) highlight decision points, contraindications, and where the protocol is strong vs uncertain using only high-quality sources such as SSC and ESC guidance SSC 2021 [1] ESC ACS 2023 [2].

Fuentes

  1. https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-guidelines-2021
  2. https://sochicar.cl/wp-content/uploads/2023/09/ehad191.pdf
  3. https://www.tkdcd.org/public/uploads/files/pdf/randomize_klinik_calismalar/2012_SHOCKII_Intraaortic-Balloon-Support-for-Myocardial-Infarction-with-Cardiogenic-Shock_NEJM.pdf
  4. https://aftershockfestival.com
  5. https://manualclinico.hospitaluvrocio.es/urgencias/emergencias-generales/shock/
  6. https://lol.fandom.com/wiki/Shok
  7. https://www.youtube.com/watch?v=zB3GzYrLUqM
  8. https://www.osakidetza.euskadi.eus/contenidos/informacion/gidep_epdt/es_def/adjuntos/gidep_shock.pdf
  9. https://music.amazon.com/en-cl/artists/B0016SKDTI/shok
  10. https://elcomercio.pe/politica/elecciones/elecciones-2026-fiscalia-de-la-nacion-aprueba-su-protocolo-para-actuacion-funcional-en-procesos-de-eleccion-de-autoridades-ultimas-noticia/
  11. https://lol.fandom.com/wiki/Shok/Statistics
  12. https://www.escardio.org/education/content-collections/focus/cardiogenic-shock-and-acute-mechanical-circulatory-support/
  13. https://emcrit.org/emcrit/2025-aha-acls-guidelines/
  14. https://sccm.org/survivingsepsiscampaign/guidelines-and-resources/surviving-sepsis-campaign-adult-guidelines
  15. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2023/12/21/16/43/2023-aha-adult-acls
  16. https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/acute-coronary-syndromes-acs-guidelines/
  17. https://www.mcmasteroptimalaging.org/full-article/plus/2023-american-heart-association-focused-update-adult-advanced-cardiovascular-111814
  18. https://www.idsociety.org/practice-guideline/surviving-sepsis-campaign-adult-guidelines-2021/
  19. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2023/12/21/16/43/2023-aha-adult-acls
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC10246868/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC9088333/
  22. https://www.acc.org/latest-in-cardiology/clinical-trials/2024/04/05/04/44/danger-shock
  23. https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2017/10/27/16/10/CULPRIT-SHOCK
  24. https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2014/05/14/22/54/IABP-SHOCK-II
  25. https://pubmed.ncbi.nlm.nih.gov/41007760/
  26. https://www.acc.org/latest-in-cardiology/articles/2018/01/22/09/02/important-trial-results-for-interventional-cardiology-from-tct-2017-and-aha-2017
  27. https://pubmed.ncbi.nlm.nih.gov/22709745/
  28. https://www.acc.org/latest-in-cardiology/articles/2024/04/02/17/02/sun-945am-danger-shock-acc-2024
  29. https://pubmed.ncbi.nlm.nih.gov/28821512/
  30. https://www.acc.org/Latest-in-Cardiology/Articles/2012/07/24/11/55/ESC-IABP-SHOCK-II
  31. https://www.abiomed.com/en-us/about-us/news-and-media/press-releases/rct-confirms-impella-cp-improves-survival-in-heart-attack-with-cs
  32. https://pubmed.ncbi.nlm.nih.gov/30586721/
  33. https://www.crf.org/crf/news-and-events/news/news/2485-should-patients-with-cardiogenic-shock-receive-culprit-lesion-only-pci-or-multivessel-pci
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC6940235/
  35. https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/04/05/04/44/danger-shock
  36. https://www.acc.org/latest-in-cardiology/clinical-trials/2017/10/27/16/10/culprit-shock
  37. https://www.thebottomline.org.uk/summaries/danger-shock-microaxial-flow-pump-in-infarct-related-cardiogenic-shock/
  38. https://www.dicardiology.com/content/culprit-lesion-only-pci-improves-outcomes-cardiogenic-shock-patients-compared-multivessel
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC6560613/
  40. https://pubmed.ncbi.nlm.nih.gov/38587239/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC9725066/
  42. https://www.acc.org/Latest-in-Cardiology/Articles/2017/10/26/12/55/mon-1pm-culprit-shock-tct-2017
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC6415997/
  44. https://pubmed.ncbi.nlm.nih.gov/32883104/
  45. https://pubmed.ncbi.nlm.nih.gov/37622654/

Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.

¿Tienes una pregunta sobre tu propio caso? Itaca responde con fuentes en segundos.

Hacer una pregunta

Más preguntas sobre choque